Our Commitment to Responsible Science
As a trusted bioanalytical CRO, we hold ourselves to the same rigorous standards in our business practices as we do in our science. Our CSR and ESG commitments reflect our dedication to long-term partnerships built on integrity, sustainability, and accountability.
Our commitment
At KCAS Bio, we believe that accelerating science responsibly and with integrity extends well beyond our laboratories. From fostering a safe and inclusive workplace to reducing our environmental footprint and upholding the highest standards of ethical governance, sustainability shapes how we operate, how we grow, and how we partner across the drug development ecosystem.
Our Chief Executive Officer and leadership team are fully committed to driving sustainability and corporate responsibility across all of KCAS Bio’s operations.
” Responsible science means delivering rigorous, high‑quality data for our clients while thoughtfully managing the impact of our operations on our people, our communities, and the world around us. ”
John Bucksath, CEO
Our first EcoVadis assessment & commitment badge
As part of our CSR and ESG initiatives launched in 2024–2025, we are pleased to share the results of our first EcoVadis sustainability assessment, which reflects our commitment to responsible and ethical practices across our US and EU sites. We are proud to have received an EcoVadis Commitment Badge, recognizing the strength of our early achievements and the foundations we’ve built for continuous improvement.
Our Responsible Procurement Policy
Our procurement decisions are guided by clear CSR and ESG standards that apply across our entire supply chain.
When it comes to responsible purchasing, we hold our suppliers and partners to the same expectations we set for ourselves across four key principles:
- Respect of human rights and working conditions
- Environmental protection
- Ethics and transparency
- Support for the local Economy and SMEs
Agile, responsive and easy to work with
We prepare and adapt our services based on a deep understanding of your drug development ambitions and wider business objectives.